01 1Shilpa Medicare
01 1POMALIDOMIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-09
Pay. Date : 2017-12-07
DMF Number : 32309
Submission : 2017-12-09
Status : Active
Type : II
20
Shilpa Pharma Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is POMALIDOMIDE, with a corresponding US DMF Number 32309.
Remarkably, this DMF maintains an Active status since its submission on December 09, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 09, 2018, and payment made on December 07, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
